Guillaume Villon de Benveniste
How to develop innovations that people buy?
This is a question that’s on every Managing Director’s mind. Consider this: European Fortune 500 companies invest well over 100B€ in innovation a year. And, yet 70% of innovations fail
Guillaume is developing a novel approach to creating innovations that people buy. He’s working with multiple global companies on innovation issues, including Pfizer, Merck, Danone, Air Liquide, Vodafone, Microsoft, Orange and Schneider.
He has helped Inova, an innovation software company, improve its product portfolio by applying the “jobs-to-be done” innovation approach, resulting in new client acquisitions.
He has worked with Alcimed, a Paris-based consultancy focused on healthcare, to create an office in the NYC/Princeton area. There, he helped leading Pharmaceutical companies move from a molecule-based business model to a solutions business model.
Before Alcimed, he has helped leading software companies, such as Microsoft and Dassault Systèmes, with their innovation capabilities.
Guillaume received his Master’s Degree (“Maîtrise”) in Philosophy at Sorbonne University in Paris and his MBA (“Diplôme Grande Ecole”) from ESSEC, a leading business school based out of Paris, France. A Virginian by birth and Frenchman by education, Guillaume is fluent in French and American English.